|
Market Closed -
Nasdaq
00:00:00 26/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.700 USD | -1.82% |
|
-13.18% | +100.00% |
| 09-16 | William Blair Initiates Zentalis Pharmaceuticals at Outperform | MT |
| 09-14 | Zentalis Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 02:35 PM |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZNTL | Delayed | |
CBOE
| ZNTL | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 3.34 | 6.61 | 6.61 |
| Spread/Res. | -19.16% | -59.15% | -59.15% |
| Spread/Supp. | +1.12% | +28.57% | +110.94% |
| Support | 2.67 | 2.1 | 1.28 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ZNTL Stock
- Charts Zentalis Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
